185
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Biological artificial fluid-induced non-lamellar phases in glyceryl monooleate: the kinetics pathway and its digestive process by bile salts

, , , , , & show all
Pages 178-185 | Received 12 Oct 2012, Accepted 15 Nov 2012, Published online: 25 Jan 2013

References

  • Guo C, Wang J, Cao F, et al. Lyotropic liquid crystal systems in drug delivery. Drug Discov Today 2010;15:1032–40
  • Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev 2001;47:229–50
  • Kaasgaard T, Drummond CJ. Ordered 2-D and 3-D nanostructured amphiphile self-assembly materials stable in excess solvent. Phys Chem Chem Phys 2006;8:4957–75
  • Rizwan SB, Boyd BJ, Rades T, Hook S. Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins. Expert Opin Drug Deliv 2010;7:1133–44
  • Svensson A, Neves C, Cabane B. Hydration of an amphiphilic excipient, Gelucire 44/14. Int J Pharm 2004;281:107–18
  • Zahid NI, Abou-Zied OK, Hashim R, Heidelberg T. Fluorescence probing of the temperature-induced phase transition in a glycolipid self-assembly: hexagonal <–> micellar and cubic <–> lamellar. Langmuir 2012;28:4989–95
  • Shah MH, Paradkar A. Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices. Eur J Pharm Biopharm 2007;67:166–74
  • Conn CE, Ces O, Mulet X, et al. Dynamics of structural transformations between lamellar and inverse bicontinuous cubic lyotropic phases. Phys Rev Lett 2006;96:108102
  • Clogston J, Caffrey M. Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids. J Control Release 2005;107:97–111
  • Ericsson B, Ericsson PO, Lofroth JE, Engstrom S. Cubic phases as delivery systems for peptide drug polymeric drug and drug delivery. Washington (DC): American Chemical Society; 1991
  • Svärd M, Schurtenberger P, Fontell K, et al. Micelles, vesicles and liquid crystals in the monoolein-sodium taurocholate-water system. Phase behavior, NMR self-diffusion and quasi-elastic light scattering studies. J Phys Chem 1988;92:2261–70
  • Zhang SZ, Xie JW, Liu CS. Microenvironmental properties and chiral discrimination abilities of bile salt micelles by fluorescence probe technique. Anal Chem 2003;75:91–7
  • Boyd BJ, Dong YD, Rades T. Nonlamellar liquid crystalline nanostructured particles: advances in materials and structure determination. J Liposome Res 2009;19:12–28
  • Zughaid H, Forbes B, Martin GP, Patel N. Bile salt composition is secondary to bile salt concentration in determining hydrocortisone and progesterone solubility in intestinal mimetic fluids. Int J Pharm 2012;422:295–301
  • Negrini R, Mezzenga R. pH-responsive lyotropic liquid crystals for controlled drug delivery. Langmuir 2011;27:5296–303
  • Phan S, Fong WK, Kirby N, et al. Evaluating the link between self-assembled mesophase structure and drug release. Int J Pharm 2011;421:176–82
  • Fong WK, Hanley T, Boyd BJ. Stimuli responsive liquid crystals provide ‘on-demand’ drug delivery in vitro and in vivo. J Control Release 2009;135:218–26
  • Alam MM, Oka T, Ohta N, Yamazaki M. Kinetics of low pH-induced lamellar to bicontinuous cubic phase transition in dioleoylphosphatidylserinemonoolein. J Chem Phys 2011;134:145102
  • Siegel DP, Epand RM. The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: implications for membrane fusion mechanisms. Biophys J 1997;73:3089–111
  • Wang Z, Zheng L, Inoue T. Effect of sucrose on the structure of a cubic phase formed from a monoolein/water mixture. J Colloid Interface Sci 2005;288:638–41
  • Wu K, McGown LB. Fluorescence probe studies of mixed micellar and lyotropic phases formed between an anionic bile salt and a cationic detergent. J Phys Chem 1994;98:1185–91
  • Costa-Balogh FO, Sparr E, Sousa JJ, Pais AC. Drug release from lipid liquid crystalline phases: relation with phase behavior. Drug Dev Ind Pharm 2010;36:470–81
  • Reeff J, Gaignaux A, Goole J, et al. New sustained-release intraarticular gel formulations based on monolein for local treatment of arthritic diseases. Drug Dev Ind Pharm 2012; DOI: 10.3109/03639045.2012.730529

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.